Friday, 26 July 2013

CDER New July 26, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

July 25, 2013


New and Generic Drug Approvals

July 24, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Cellcept mycophenolate mofetil Suspension; Oral Roche Palo Manufacturing Change or Addition
Donepezil Hydrochloride donepezil hydrochloride Tablet; Oral Par Pharm Approval
Donepezil Hydrochloride donepezil hydrochloride Tablet; Oral Macleods Pharma Tentative Approval
Donepezil Hydrochloride donepezil hydrochloride Tablet; Oral Dr Reddys Labs Ltd Approval
Invanz ertapenem sodium Injectable; Intramuscular, Iv (Infusion) Merck Sharp Dohme Labeling Revision
Lo Minastrin Fe norethindrone acetate; ethinyl estradiol; ethinyl estradiol; ferrous fumarate Tablet, Chewable, Tablet; Oral Warner Chilcott Llc Approval
Norvasc amlodipine besylate Tablet; Oral Pfizer Manufacturing Change or Addition
Pediatric Advil ibuprofen Suspension/Drops; Oral Pfizer Manufacturing Change or Addition
Viread tenofovir disoproxil fumarate Tablet; Oral Gilead Sciences Inc Efficacy Supplement with Clinical Data to Support
Viread tenofovir disoproxil fumarate Powder; Oral Gilead Sciences Inc Efficacy Supplement with Clinical Data to Support
Zingo lidocaine hydrochloride System; Intradermal Powder Pharms Manufacturing Change or Addition

 


This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

No comments:

Post a Comment